Bank of America
VBIO

Bank of America’s Valion Bio VBIO Stock Holding History

Bank of America’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13
Closed -$19 – 6812
2025
Q4 		$19 Buy
13
+5
+63% +$11 ﹤0.01% 7138
2025
Q3 		$23 Sell
8
-1
-11% -$3 ﹤0.01% 8147
2025
Q2 		$37 Buy
9
+4
+80% +$17 ﹤0.01% 8162
2025
Q1 		$13 Buy
5
+1
+25% +$5 ﹤0.01% 8193
2024
Q4 		$24 Buy
4
+1
+33% +$5 ﹤0.01% 7998
2024
Q3 		$13 Sell
3
-1
-25% -$6 ﹤0.01% 8022
2024
Q2 		$25 Buy
+4
New +$50 ﹤0.01% 7965
2023
Q1 		– Hold
0
– -$8 – 8266
2022
Q4 		– Hold
0
– – – 8102

Other funds holding VBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Bank of America's VBIO Position: Q1 2026 in Review

Bank of America sold out of Valion Bio (VBIO) in Q1 2026, closing a stake of 13 shares — an estimated $19 sold.

Bank of America first reported a position in VBIO in Q2 2024 and held it in 7 quarters. The position peaked at $37 in Q2 2025. 9 funds tracked by Wall St. Rank hold VBIO as of Q1 2026.

  • Bank of America reported no remaining Valion Bio position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 13 Valion Bio shares in Q1 2026, an estimated $19.
  • Bank of America first reported a position in Valion Bio in Q2 2024 and held it in 7 quarters.
  • Bank of America's Valion Bio position peaked at $37 in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Valion Bio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.